Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03162328 · ClinicalTrials.gov registry record · NA
A Study of the Effectiveness and Efficacy of the PowerSleep Device
A NA study of Healthy and Sleep Deprivation, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 7
- Study locations
NCT03162328 is a NA study of Healthy and Sleep Deprivation that has completed, run by Philips Respironics. The registered enrollment target is 84 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT03162328, a NA study of Healthy and Sleep Deprivation, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study is a randomized, double-blind, placebo-controlled cross-over study designed to evaluate the effectiveness and efficacy of 2 consecutive work days of nightly use of active versus sham PowerSleep devices in adults with self-imposed restricted sleep schedules. The primary analysis will be intent-to-treat with the secondary analysis as an as-treated analysis. The expected duration of the study for each participant is up to 4 weeks.
Conditions Studied
Interventions
- DEVICE PowerSleep Stim
- DEVICE PowerSleep Sham
Study Locations (7)
Alabama
- Sleep Disorders Center of Alabama - Birmingham
Arkansas
- Arkansas Center for Sleep Medicine - Little Rock
Florida
- Florida Lung & Sleep Associates - Lehigh Acres
Georgia
- NeuroTrials Research Inc. - Atlanta
Maryland
- Center for Sleep and Wake Disorders - Chevy Chase
Missouri
- Clayton Sleep Institute - St Louis
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2017-04-25 |
| Est. Completion | 2017-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03162328
The ClinicalTrials.gov registry entry for NCT03162328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which PowerSleep Stim is the first listed.
NCT03162328 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, Arkansas, Florida.
Frequently Asked Questions
What is clinical trial NCT03162328 about?
NCT03162328 is a clinical study titled "A Study of the Effectiveness and Efficacy of the PowerSleep Device". This study is a randomized, double-blind, placebo-controlled cross-over study designed to evaluate the effectiveness and efficacy of 2 consecutive work days of nightly use of active versus sham PowerSleep devices in adults with self-imposed restricted sleep schedules. The primary analysis will be in...
What is the current status of trial NCT03162328?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2017-04-25. Estimated completion is 2017-11-10.
What conditions does trial NCT03162328 study?
This clinical trial studies the following conditions: Healthy, Sleep Deprivation, Insufficient Sleep Syndrome.
What interventions are being tested in trial NCT03162328?
The interventions under investigation include: PowerSleep Stim (DEVICE), PowerSleep Sham (DEVICE).
Who is sponsoring clinical trial NCT03162328?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03162328 being conducted?
This trial has 7 study locations across Alabama, Arkansas, Florida, Georgia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.